Corona: Trump’s drug Remdesivir approved in Switzerland



[ad_1]

The antiviral remdesivir can be used in Switzerland. This was announced by the manufacturer, the American pharmaceutical company Gilead. The drug was part of the antibody cocktail received by the President of the United States, Donald Trump (74), during his crown disease in October. It was originally developed to fight the Ebola virus.

The order is out. Limited approval with conditions has been granted, ”a spokesperson for the Swissmedic Therapeutic Products Institute confirms to BLICK. The product has been used in Switzerland to treat adult patients with Covid-19 since the beginning of July. However, until now, its use was only allowed in the context of clinical studies or on special orders from the doctor.

[ad_2]